Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jaros

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Movement Disorders|January 21, 2016
Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trialsWilliam G Ondo, Neal Hermanowicz, Diego García Borreguero, et al.
CNS Drugs|April 21, 2016
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled TrialsNeal Hermanowicz, Aaron Ellenbogen, Gordon Irving, et al.
Annals of Medicine|April 16, 2015
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbilRichard K Bogan, Daniel O Lee, Mark J Buchfuhrer, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patientsJulian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics|March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometryJulian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics|May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controlsJulian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial ResultsJason Bacharach, David L Wirta, Robert Smyth-Medina, et al.
Medical Physics|December 30, 2016
Beam distortion due to gold fiducial markers during salvage high-intensity focused ultrasound in the prostateP S Georgiou, J Jaros, H Payne, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2021
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical TrialsDavid L Wirta, Michael S Korenfeld, Shane Foster, et al.
Kardiologia Polska|September 3, 2014
Oxygen uptake during Nordic walking training in patients rehabilitated after coronary eventsJerzy R Rybicki, Bożena M Leszczyńska-Bolewska, Wiesława E Grochulska, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Movement Disorders|January 21, 2016
Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trialsWilliam G Ondo, Neal Hermanowicz, Diego García Borreguero, et al.
CNS Drugs|April 21, 2016
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled TrialsNeal Hermanowicz, Aaron Ellenbogen, Gordon Irving, et al.
Annals of Medicine|April 16, 2015
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbilRichard K Bogan, Daniel O Lee, Mark J Buchfuhrer, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patientsJulian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics|March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometryJulian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics|May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controlsJulian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial ResultsJason Bacharach, David L Wirta, Robert Smyth-Medina, et al.
Medical Physics|December 30, 2016
Beam distortion due to gold fiducial markers during salvage high-intensity focused ultrasound in the prostateP S Georgiou, J Jaros, H Payne, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2021
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical TrialsDavid L Wirta, Michael S Korenfeld, Shane Foster, et al.
Kardiologia Polska|September 3, 2014
Oxygen uptake during Nordic walking training in patients rehabilitated after coronary eventsJerzy R Rybicki, Bożena M Leszczyńska-Bolewska, Wiesława E Grochulska, et al.
Pageof 5